Latest filing published 09 Dec 2020 for GenMark Diagnostics, Inc., €8,552. Read the official filing
All filings by Scott Alexander O'Brien on record concern GenMark Diagnostics, Inc. Over a trading history stretching from 29 April 2020 to 7 December 2020, the count stands at 13 filings.
No open-market purchase appears, only 13 sales worth €548k.
On 9 December 2020 came the latest disclosure, an open-market sale for €8,552 in GenMark Diagnostics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations